Sort
326,823 grants matching “clinical trial”
Duke SPORE in Brain Cancer
$1,984,462John H Sampson · Duke University · P50 · FY2020 · CA
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$1,984,309Jessica Alber · University Of Rhode Island · R01 · FY2025 · AG
Upstate Carolina Community Clinical Oncology Program
$1,984,251James D Bearden · Spartanburg Regional Medical Center · U10 · FY2006 · CA
Two-Stage Genome-Wide Association Study in Systemic Sclerosis
$1,984,223Maureen Maureen Mayes · University Of Texas Hlth Sci Ctr Houston · R01 · FY2008 · AR
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)
$1,984,101Judith S Hochman · New York University School Of Medicine · R01 · FY2022 · HL
Gastroparesis Clinical Research Consortium - Data Coordinating Center
$1,984,099James A Tonascia · Johns Hopkins University · U01 · FY2010 · DK
ADULT AIDS CLINICAL TRIALS UNIT
$1,984,093Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2001 · AI
IMPACTA PERU CLINICAL TRIALS UNIT
$1,984,088Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2016 · AI
A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION
$1,984,084Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2018 · AI
Genetic Approaches to Cancer Immunotherapy
$1,984,035Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
SCCOR in translational research in Acute Lung Injury
$1,983,955University Of California San Francisco · P50 · FY2005 · HL
Pharmacological Treatment of Retinal Diseases
$1,983,634Krzysztof Palczewski · Case Western Reserve University · R24 · FY2012 · EY
TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT
$1,983,627Caroline C Sigman · Ccs Associates, Inc. · N02 · FY2015 · CA
The CAPTURE Study: Validating a unique COPD screening tool in primary care
$1,983,602Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,983,570Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2023 · CA
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
$1,983,531Anthony Andrew Oliva · Longeveron, Llc · R44 · FY2019 · AG
TREATMENT RESEARCH CENTER--BEHAVIORAL PHARMACOLOGY
$1,983,351Johns Hopkins University · P50 · FY2000 · DA
Impact of FGF21 on healthspan and lifespan
$1,983,293Vishwa Deep Dixit · Yale University · P01 · FY2020 · AG
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$1,983,212Steven Jacobson · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Molecular Genetics of Fanconi Anemia
$1,983,074Robb E Moses · Oregon Health & Science University · P01 · FY2006 · HL
Development of TP-352 for the Treatment of Pediatric Non-alcoholic Steatohepatitis
$1,982,861Frank Sciavolino · Thetis Pharmaceuticals, Llc · R44 · FY2020 · DK
Product Development and Manufacture
$1,982,812Robert T McNally · Geovax, Inc. · U19 · FY2009 · AI
RSK3 Anchoring Disruptor Therapy for Heart Failure
$1,982,787Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2024 · HL
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$1,982,660John E Wagner · University Of Minnesota · P01 · FY2024 · CA
CANCER CENTER SUPPORT GRANT
$1,982,572University Of Virginia Charlottesville · P30 · FY2003 · CA